Napolitano Mariasanta, Siragusa Sergio, Mariani Guglielmo
Hematology Unit-Reference Regional Center for Thrombosis and Hemostasis, Università di Palermo, 90127 Palermo, Italy.
Westminster University, London W1B 2HW, UK.
J Clin Med. 2017 Mar 28;6(4):38. doi: 10.3390/jcm6040038.
Factor VII deficiency is the most common among rare inherited autosomal recessive bleeding disorders, and is a chameleon disease due to the lack of a direct correlation between plasma levels of coagulation Factor VII and bleeding manifestations. Clinical phenotypes range from asymptomatic condition-even in homozygous subjects-to severe life-threatening bleedings (central nervous system, gastrointestinal bleeding). Prediction of bleeding risk is thus based on multiple parameters that challenge disease management. Spontaneous or surgical bleedings require accurate treatment schedules, and patients at high risk of severe hemorrhages may need prophylaxis from childhood onwards. The aim of the current review is to depict an updated summary of clinical phenotype, laboratory diagnosis, and treatment of inherited Factor VII deficiency.
凝血因子VII缺乏症是罕见的常染色体隐性遗传性出血性疾病中最常见的一种,由于凝血因子VII的血浆水平与出血表现之间缺乏直接相关性,它是一种具有多样性的疾病。临床表型范围从无症状状态(即使是纯合子个体)到严重的危及生命的出血(中枢神经系统、胃肠道出血)。因此,出血风险的预测基于多个影响疾病管理的参数。自发性出血或手术出血需要精确的治疗方案,严重出血高风险的患者可能需要从儿童期就开始预防。本综述的目的是描述遗传性凝血因子VII缺乏症的临床表型、实验室诊断和治疗的最新总结。